Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DWP212525 in Healthy Volunteers
NCT06736587Phase 1Recruiting
- Sponsor
- Daewoong Pharmaceutical
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of DWP212525 in autoimmune disease (11 cohorts), sponsored by Daewoong Pharmaceutical. Primary endpoints: Pharmacokinetic profiles of DWP212525 at Day 1 and Safety profiles at Day 1. Started Dec 2024; status: recruiting.
02
Drugs
DWP212525
03
Conditions
autoimmune disease
Beyond the preview
Go deeper on NCT06736587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06736587.